Embryonic cardiomyocyte, but not autologous stem cell transplantation, restricts infarct expansion, enhances ventricular function, and improves long-term survival.
Paulis LE, Klein AM, Ghanem A, Geelen T, Coolen BF, Breitbach M, Zimmermann K, Nicolay K, Fleischmann BK, Roell W, et al. PLoS One. 2013; 8(4):e61510. Epub 2013 Apr 9.